Legal Biological Agreement

LEGAL BIOLOGICAL AGREEMENT

This Legal Biological Agreement ("Agreement") is entered into as of Effective Date: by and between Provider Name: and Recipient Name: .

RECITALS

WHEREAS, Provider possesses certain biological materials, including but not limited to cells, cell lines, tissues, reagents, and associated proprietary information, described in Section 2 below (the "Materials"); and

WHEREAS, Recipient desires to receive the Materials from Provider for the limited Research Purpose described below and agrees to accept and use the Materials subject to the terms and conditions of this Agreement; and

WHEREAS, Provider is willing to provide the Materials to Recipient subject to restrictions on use, redistribution, and ownership of derivatives as set forth herein.

NOW, THEREFORE, in consideration of the mutual covenants and promises contained herein, the parties agree as follows:

1. DEFINITIONS

1.1 "Materials" means the biological materials, associated documentation, and any Provider-supplied reagents listed in Section 2. Materials do not include Provider's background intellectual property unless explicitly licensed in writing.

1.2 "Research Purpose" means the use of the Materials as described by Recipient below for non-clinical laboratory research only and expressly excluding any diagnostic, therapeutic, clinical trial, or commercial use unless a separate license is executed.

2. DESCRIPTION OF MATERIALS AND PURPOSE

3. PERMITTED USE AND RESTRICTIONS

3.1 Recipient shall use the Materials solely for the Research Purpose and shall not use the Materials for: human administration, clinical diagnostic purposes, commercial production, or any use that would create a clinical product for use in humans or animals without Provider's prior written license.

3.2 Recipient shall not distribute, transfer, sublicense, or otherwise provide the Materials to any third party without Provider's prior written consent. Subcontracts for laboratory services are permitted only if Provider's prior written consent is obtained and if the subcontractor agrees in writing to comply with the terms of this Agreement.

3.3 Prohibited actions (check all that apply):
Use in human subjects or human administration
Clinical diagnostic or therapeutic use
Commercial manufacturing or sale without license
Propagation, genetic modification, or derivation beyond specified scope

4. BIOSAFETY AND COMPLIANCE

4.1 Recipient represents and warrants that it maintains facilities, personnel, training, and protocols required to handle the Materials in accordance with applicable biosafety standards and governmental regulations. Recipient shall comply with all applicable laws, regulations, and institutional policies relating to the handling, storage, use, and disposal of the Materials.

5. CONFIDENTIALITY

5.1 Recipient shall hold in confidence all Confidential Information disclosed by Provider in connection with the Materials. "Confidential Information" includes non-public information concerning the Materials, processes, and any Provider-provided protocols. Confidential Information does not include information that is or becomes publicly known through no fault of Recipient.

6. INTELLECTUAL PROPERTY

6.1 Provider retains all right, title and interest in and to the Materials and any Provider intellectual property embodied therein. No right, title or license to such intellectual property is granted except as expressly set forth in this Agreement.

6.2 Subject to the ownership rights of Provider, Recipient shall own any inventions or data that are solely the result of Recipient's activities with the Materials. For inventions that arise from the joint activities of Provider and Recipient, ownership and rights shall be negotiated in good faith and memorialized in a separate written agreement.

7. PUBLICATION

7.1 Recipient may publish or present results obtained using the Materials, provided that Recipient provides Provider with a copy of any proposed manuscript, abstract, or presentation at least thirty (30) days prior to submission to allow Provider to identify patentable subject matter or confidential information. Provider's review shall be limited to protecting patentable inventions or Confidential Information and shall not unreasonably delay publication.

8. INDEMNIFICATION AND INSURANCE

8.1 Recipient shall indemnify, defend and hold harmless Provider, its officers, directors and employees from and against any claims, liabilities, damages, losses, or expenses (including reasonable attorneys' fees) arising out of Recipient's use of the Materials, except to the extent caused by Provider's gross negligence or willful misconduct.

9. LIMITATION OF LIABILITY

9.1 EXCEPT FOR A PARTY'S INDEMNIFICATION OBLIGATIONS OR LIABILITY ARISING FROM THAT PARTY'S FRAUD, GROSS NEGLIGENCE OR WILLFUL MISCONDUCT, NEITHER PARTY SHALL BE LIABLE TO THE OTHER FOR INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL OR PUNITIVE DAMAGES ARISING OUT OF THIS AGREEMENT.

10. TERM AND TERMINATION

10.1 This Agreement shall commence on the Effective Date and shall continue until terminated by either party upon thirty (30) days' written notice, or earlier in accordance with Section 10.2.

10.2 Provider may terminate this Agreement immediately upon written notice if Recipient breaches any term of this Agreement, uses the Materials in prohibited ways, or fails to maintain required approvals or biosafety practices.

11. RETURN OR DESTRUCTION OF MATERIALS

11.1 Upon expiration or termination, Recipient shall, at Provider's election, either return all remaining Materials to Provider or destroy the Materials and provide Provider with a written certificate of destruction signed by an authorized representative.

12. RECORDS, AUDIT AND INSPECTION

12.1 Recipient shall maintain complete and accurate records of receipt, storage, use, transfer, and disposal of Materials. Provider or its designee shall have the right, upon reasonable written notice and during normal business hours, to inspect Recipient's records and facilities to verify compliance with this Agreement.

13. FEES AND TRANSPORTATION

13.1 If applicable, Recipient shall pay Provider the fee for the Materials and any shipping, handling, and insurance charges as set forth in the attached order or purchase confirmation. Fees are due within the payment terms agreed in writing.

14. NOTICES

14.1 All notices required or permitted under this Agreement shall be in writing and shall be delivered personally, sent by certified mail (return receipt requested), nationally recognized overnight courier, or by email with confirmation of receipt to the addresses set forth below.

15. AMENDMENTS; WAIVER; COUNTERPARTS

15.1 This Agreement may be amended or modified only by a written instrument executed by authorized representatives of both parties. No waiver by either party of any breach shall be deemed a waiver of any subsequent breach.

15.2 This Agreement may be executed in counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument. Delivery of an executed counterpart by electronic transmission shall be effective as delivery of an original.

16. GOVERNING LAW; ENTIRE AGREEMENT; SEVERABILITY

16.1 This Agreement shall be governed by and construed in accordance with the laws of the State of without regard to conflict of laws principles.

16.2 This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements and understandings, whether written or oral.

16.3 If any provision of this Agreement is held to be invalid or unenforceable, the remaining provisions shall continue in full force and effect.

17. MISCELLANEOUS

17.1 The parties acknowledge that monetary damages may be inadequate to remedy a breach of certain provisions of this Agreement and that Provider shall be entitled to seek injunctive relief in addition to any other remedies available at law or in equity.

Sign Now